INmune Bio Inc. Announces First Quarter 2023 Results and

Company to Host Conference Call Today, May 3, at 4:30pm ET...

Related Keywords

Australia ,United Kingdom ,United States ,Greece ,Raton ,Perifereia Peloponnisou ,Canada ,Athens ,Attikír ,American ,Jason Nelson ,Inmune Biocontact ,Mark Lowdell ,David Moss ,Inmune Bio ,International Society Of Cell Gene Therapy ,American Association For Cancer Research ,Company Annual Report On Form ,Inmune Bio Inc ,Nasdaq ,Attikon University Hospital ,Exchange Commission ,Company Quarterly Reports On Form ,Drug Administration ,Company Current Reports On Form ,Mild Cognitive Impairment Phase ,Muscular Dystrophy ,American Association ,Cancer Research ,Traumatic Brain Injury ,Royal Hallamshire Hospital ,Sheffield University Medical School ,Innate Killer Summit ,Presidential Session ,International Society ,Gene Therapy ,Treatment Resistant Depression ,Resultsforthe Quarterended March ,Bio First Quarter Conference Call ,Dominant Negative Tumor Necrosis Factor ,Mild Alzheimer ,Mild Cognitive Impairment ,Natural Killer Cell Priming Platform ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Three Months ,Nasdaq Inmb ,Nc ,